Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:3480629.
doi: 10.1155/2016/3480629. Epub 2016 Aug 14.

Could Metformin Manage Gestational Diabetes Mellitus instead of Insulin?

Affiliations

Could Metformin Manage Gestational Diabetes Mellitus instead of Insulin?

Hend S Saleh et al. Int J Reprod Med. 2016.

Abstract

Gestational diabetes mellitus (GDM) complicates a significant number of pregnancies. Blood glucose control improves perinatal outcomes. Medical nutrition therapy is the foundation in management. Aim of This Study. To evaluate efficacy of metformin in comparison to insulin for managing GDM. Methods. In prospective randomized comparative study, 150 antenatal women whose pregnancies had been complicated by GDM and did not respond to diet alone were recruited from antenatal clinics at Obstetrics Department in Zagazig University Hospitals from November 2012 to December 2014. They were divided randomly into two groups, 75 patients in each, and were subjected to either insulin or metformin medication. Outcomes were comparing the effects of both medications on maternal glycemic control, antenatal complications, and neonatal outcome. Results. No significant difference in controlling high blood sugar in GDM with the use of metformin or insulin (P = 0.95, 0.15). Maternal complications in both groups had no significant difference and fetal outcomes were as well similar except the fact that the hypoglycemia occurred more in insulin group with P value 0.01. Conclusion. Glycaemic control in GDM can be achieved by using metformin orally without increasing risk of maternal hypoglycemia with satisfying neonatal outcome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study in flow chart.
Figure 2
Figure 2
The figure shows pattern of blood sugar in both groups before and after treatment (fasting blood sugar (FBS) and 2 h postprandial blood sugar (2 h PPBS)).
Figure 3
Figure 3
The figure shows % of modes of deliveries in metformin group.
Figure 4
Figure 4
The figure shows % of modes of deliveries in insulin group.

Similar articles

Cited by

References

    1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(supplement 1):S5–S20. - PubMed
    1. National Diabetes Information Clearinghouse (NIDC) Diabetes Overview. National Diabetes Information Clearinghouse. NIH Publication; 2008.
    1. Maymone A. C., Baillargeon J.-P., Ménard J., Ardilouze J.-L. Oral hypoglycemic agents for gestational diabetes mellitus? Expert Opinion on Drug Safety. 2011;10(2):227–238. doi: 10.1517/14740338.2011.521740. - DOI - PubMed
    1. Ben-Haroush A., Yogev Y., Hod M. Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabetic Medicine. 2004;21(2):103–113. doi: 10.1046/j.1464-5491.2003.00985.x. - DOI - PubMed
    1. Metzger B. E., Gabbe S. G., Persson B., et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–682. doi: 10.2337/dc09-1848. - DOI - PMC - PubMed

LinkOut - more resources